FDA approves Bayer's Stivarga to treat most common liver cancer

The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in nearly a decade.

Source: http://www.reuters.com/article/us-bayer-cancer-liver-idUSKBN17T2PU


POSTED:2016-07-20 19:58:04

AUTHOR: sllishay ken

POSTED:2017-07-04 15:04:11

AUTHOR: Timothy L Fortin

2nd line treatment soon to be over taken by immunotherapy in my opinion

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.